Search Results 91-100 of 19791 for Expanding
In a continued effort to provide greater efficiency in caring for our patients, improve patient safety and offer advanced services to inpatient areas, ...
A multicenter, open-label expanded access protocol for the treatment of subjects with relapsed/refractory large B-cell lymphoma. Participation eligibility.
The purpose of this study is to provide access to the VT-X7 (Vancomycin, Tobramycin Exchanged in 7 Days) system for subjects with periprosthetic joint infection ...
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney) · Overview · Participation eligibility.
Early symptoms have included fever, cough and chills. The list of symptoms in people with confirmed COVID-19 disease has expanded since early reports of the ...
Expand knowledge about some of the rarest varieties of chondrosarcoma; Improve the ability to tailor the treatment of less-aggressive chondrosarcomas. Mayo ...
The FDA authorized the Convalescent Plasma Expanded Access Program for the use of convalescent plasma for patients infected with SARS-CoV-2, the virus that ...
Expanded Access Study for the Treatment of Patients With Commercially Out-of-Specification Axicabtagene Ciloleucel · Overview · Participation eligibility.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors · Share · Facebook ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.